Furthermore, ricolinostat (ACY-1215), a selective HDAC6 inhibitor, has been shown to induce apoptosis and G2/M arrest in ESCC cells through the PI3K/AKT/mTOR and ERK pathways, which were then confirmed in vivo94. This evidence concerns the gene MTOR and esophageal squamous cell carcinoma.